Now could be a good time to consider buying this cannabis stock

132 0

Curaleaf Holdings is a name that resonates well in the cannabis investment space

Marijuana stocks, like all growth stocks, did not have a pleasant 2022. With federal reform increasingly uncertain, investors will have to wait a little longer to reap some of the benefits. This is not to say that there are some companies with extraordinary potential to become much bigger and stronger as time goes on. At the end of the day, all growth stocks started from the bottom, and only those who are confident in their performance will be able to reap the rewards in the future.

According to several experts, Curaleaf Holdings is a smart buy as its stock is trading at a discount and continues to have solid fundamentals, as well as growing revenues and well-established targets. Many of the national companies have strongly expanded their footprint in the marijuana market, bringing their operations to all those states that have allowed the legalization of the plant in one form or another.

This concept is where Curaleaf excels. The Massachusetts-based company posted 2021 revenues in excess of $1.2 billion. Since then, the company has made some strategic moves and timely acquisitions that have really paid off. Select, Curaleaf NJ, Blue Kudu, Remedy and Grassroots are a few brands that now rule under its umbrella and have proven solid enough to take its revenues to the next level.

One of the wisest visions was to target limited license markets to generate revenue and a loyal customer base. After learning that cannabis remains illegal at the federal level, Curaleaf has focused on those states where regulators carefully select companies operating in their jurisdictions. As a result, the firm has limited competition and a consistently returning customer base.